| Zhang, Helong |
TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment |
|
|
| Active, not recruiting | 3 | 531 | RoW | JS001, Nab-Paclitaxel, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Triple-Negative Breast Cancer | 12/24 | 12/25 | | |
NCT04990063: Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC) |
|
|
| Recruiting | 1 | 20 | RoW | Chemotherapy, Adoptive TKC transfer therapy | suhaichuan, Shanghai Biomed-union Biotechnology Co., Ltd. | Advanced Non-small Cell Lung Cancer, Chemotherapy | 08/22 | 11/23 | | |
| Jiang, Tao |
NCT04934059: Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS). |
|
|
| Not yet recruiting | 4 | 60 | RoW | Yuxuebi tablet, Placebo tablet | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | Ankylosing Spondylitis | 01/22 | 01/22 | | |
pcwaintrl, NCT05387109: Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer |
|
|
| Not yet recruiting | 4 | 41 | NA | penpulimab combined with anlotinib | Tang-Du Hospital | NSCLC | 04/23 | 04/24 | | |
NCT05188989: Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction. |
|
|
| Completed | 3 | 765 | RoW | TPN171H 2.5mg group, Simmerafil, TPN171H 5mg group, TPN171H 10mg group, Placebo group | Vigonvita Life Sciences | Erectile Dysfunction | 02/23 | 02/23 | | |
NCT06301854: Long-term Safety of TPN171H Tablet in Erectile Dysfunction. |
|
|
| Recruiting | 3 | 472 | RoW | TPN171H, Simmerafil | Vigonvita Life Sciences | Erectile Dysfunction | 04/25 | 04/25 | | |
| Recruiting | 3 | 170 | Europe, Canada, Japan, US, RoW | Selpercatinib, LY3527723, LOXO-292, Placebo | Loxo Oncology, Inc., Eli Lilly and Company | Carcinoma, Non-Small-Cell Lung | 05/27 | 08/32 | | |
NCT05388825: Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction |
|
|
| Completed | 2 | 84 | RoW | TPN171H 2.5mg, TPN171H 5mg, TPN171H 10mg, Placebo 5mg, Placebo 10mg | Vigonvita Life Sciences | Erectile Dysfunction | 01/23 | 02/23 | | |
NCT05055583: Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC |
|
|
| Recruiting | 2 | 30 | RoW | Toripalimab in Combination With Platinum-based Chemotherapy, Toripalimab Injection, JS001, Teruipuli Dankang, TuoYI, Surgical treatment stage, Adjuvant treatment stage | Tang-Du Hospital | NSCLC Stage IV, Oligometastasis | 08/23 | 12/23 | | |
NCT05247216: A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis |
|
|
| Completed | 2 | 140 | RoW | Hemay007 800 mg QD group, Hemay007 1200 mg QD group, Hemay007 600 mg QD group, Hemay007 placebo group | Tianjin Hemay Pharmaceutical Co., Ltd | Rheumatoid Arthritis | 06/23 | 06/23 | | |
NCT06451640: A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps |
|
|
| Recruiting | 2 | 60 | RoW | 210mg of TQC2731 injection, 420mg of TQC2731 injection | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Chronic Rhinosinusitis With Nasal Polyps | 05/25 | 02/26 | | |
NCT06663059: Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study |
|
|
| Recruiting | 2 | 80 | RoW | Adebrelimab combined with albumin-bound paclitaxel and cisplatin 2 cycle, Adebrelimab combined with albumin-bound paclitaxel and cisplatin 4 cycle | Tang-Du Hospital | Esophageal Cancer | 12/25 | 09/27 | | |
NCT06036927: A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps |
|
|
| Recruiting | 2 | 80 | RoW | TQC2731 injection, TQC2731 matching placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Sinusitis, Nasal Polyps | 07/25 | 09/25 | | |
NCT05124951: The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors |
|
|
| Recruiting | 2 | 150 | RoW | Whole-ventricle irradiation, Carboplatin/etoposide, Ifosfamide/cisplatin/etoposide, Second-look surgery | Beijing Tiantan Hospital | Intracranial Germ Cell CNS Tumor, Childhood | 10/26 | 10/26 | | |
NCT06006650: Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell |
|
|
| Recruiting | 2 | 114 | RoW | Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin | Tang-Du Hospital | Neoadjuvent, PD-1 Inhibitor, Chemotherapy, Esophageal Squamous Cell Carcinoma | 12/31 | 12/31 | | |
NCT05577091: Tris-CAR-T Cell Therapy for Recurrent Glioblastoma |
|
|
| Recruiting | 1 | 10 | RoW | Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes., Autologous Tris-CAR-T cell. | Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Tasly Pharmaceutical Group Co., Ltd | Recurrent Glioblastoma | 11/24 | 11/32 | | |
ATM, NCT04706338: Transcranial Magnetic Stimulation in the Rehabilitation of Postoperative Motor Dysfunction. |
|
|
| Recruiting | N/A | 30 | RoW | TMS treatment | Beijing Neurosurgical Institute | Glioma, Postoperative Motor Deficit | 06/21 | 01/22 | | |
| Recruiting | N/A | 100 | RoW | the Cover group, the Fill group, the peeling group | Second Affiliated Hospital, School of Medicine, Zhejiang University | Macular Holes | 06/21 | 09/21 | | |
| Recruiting | N/A | 60 | RoW | | Beijing Neurosurgical Institute | Gliomas | 01/22 | 01/25 | | |
| Recruiting | N/A | 135 | RoW | LITT, Control | Beijing Tiantan Hospital | Recurrent High Grade Glioma | 03/26 | 09/27 | | |
NCT05143788: Strategic Intervention on Preserving Motor Function During Awake Craniotomy |
|
|
| Not yet recruiting | N/A | 60 | NA | Awake craniotomy | Beijing Neurosurgical Institute, Beijing Tiantan Hospital | Glioma | 12/23 | 12/23 | | |
NCT05803057: Accelerating Motor Recovering in Patients With SMA Syndrome After Glioma Surgery by Using nrTMS |
|
|
| Recruiting | N/A | 64 | RoW | TMS stimulation treatment, TMS stimulation sham-treatment | Beijing Neurosurgical Institute | Motor Cortex; Lesion, Glioma, Supplementary Motor Area Syndrome | 03/24 | 03/25 | | |
NCT05901844: Evaluate the Accuracy of Raman IVD Analyzer in the Diagnosis of Gliomas During Surgery |
|
|
| Not yet recruiting | N/A | 256 | NA | Paraffin pathological diagnosis, Raman analyzer diagnosis | Beijing Tiantan Hospital, West China Hospital, The First Affiliated Hospital of Zhengzhou University, Capital Medical University, Jiangsu Raman Medical Equipment Co., Ltd. | Glioma | 06/24 | 10/24 | | |
NCT05638269: A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China |
|
|
| Recruiting | N/A | 12000 | RoW | no intervention | Zhujiang Hospital, National Natural Science Foundation of China | Essential Hypertension, Liver Cancer, Nasopharyngeal Cancer, Pancreatic Cancer, Lung Cancer, Chronic Kidney Diseases, Acute Coronary Syndrome, Epilepsy, Gastric Cancer, Primary Aldosteronism, Subclinical hypothyroïdism | 12/24 | 12/25 | | |
NCT04425798: Connectivity Alterations After Levetiracetam Application |
|
|
| Not yet recruiting | N/A | 30 | RoW | | Beijing Neurosurgical Institute, Beijing Tiantan Hospital | Glioma, Epilepsy | 05/22 | 09/22 | | |
NCT05167604: Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC |
|
|
| Recruiting | N/A | 150 | RoW | Adjuvants, Pharmaceutic, adjuvant chemotherapy | Tang-Du Hospital | Carcinoma, Non-Small-Cell Lung, Next-Generation Sequencing, Chemotherapy, Adjuvant, Neoplasm, Residual, Circulating Tumor DNA | 09/23 | 12/24 | | |
NCT05124964: Prospective Study on Quality of Life in Patients With Intracranial Germ Cell Tumors |
|
|
| Recruiting | N/A | 150 | RoW | PedsQL 4.0 Scale, PedsQL 4.0 Generic Core Scale, Short Form-36, SF-36, Chinese Wechsler Intelligence Scale for Children, C-WISC | Beijing Tiantan Hospital | Quality of Life | 10/26 | 10/26 | | |
GRIPP, NCT05672043: Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China |
|
|
| Recruiting | N/A | 400 | RoW | | Beijing Tiantan Hospital | Medulloblastoma, Central Nervous System Tumor, Pediatric, Ependymoma, Germ Cell Tumor, Glioma, Brain Tumor, Pediatric | 12/27 | 12/32 | | |
| Zhao, Huadong |
TQB2450-III-06, NCT04405505: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC) |
|
|
| Not yet recruiting | 3 | 332 | RoW | TQB2450, Anlotinib, Paclitaxel for Injection (albumin bound) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Triple Negative Breast Cancer | 07/22 | 07/22 | | |
